InsidersTradesSigma
Follow the CENTENE CORP stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, CENTENE CORP has logged 391 public disclosures. Market capitalisation: €32.3bn. The latest transaction was reported on 27 August 2026 (Cession). Among the most active insiders: Burdick Kenneth A. Every trade is accessible without an account.
391
Insider Decl.
n/a
Thresholds
€8m
16 ops.
Buy Volume
€21m
36 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CENTENE CORP Buy (bullish), based on 18 analysts. Average price target: US$71.67.
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,036 of 29,056 companies
31.2
score / 100
Value49
Quality14
FCF yld14%
Earn yld-21%
EV/EBITDA·
ROE-20%
Gross mgn7.1%
Net mgn-3.4%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 August 2026
Declarations391 total
56,500 shares@ US$66.90Common StockSEC:0001071739-26-000169:0
43,600 shares@ US$65.000.0088% mcap9.4% of flowCommonSEC144:0001959173-26-006473
56,500 shares@ US$66.900.012% mcap21.3% of flowCommonSEC144:0001959173-26-006459
47,603 shares@ US$65.360.0097% mcap22.5% of flowCommon StockSEC:0001071739-26-000167:0
47,603 shares@ US$65.35850.0097% mcap29.0% of flowCommonSEC144:0001959173-26-006161
100,000 shares@ US$68.15180.021% mcap25.3% of flowCommonSEC144:0001959173-26-005683
2,771 shares0Common StockSEC:0001071739-26-000158:0
3,155 shares0Common StockSEC:0001071739-26-000146:0
562 sharesCommon StockSEC:0001071739-26-000140:0
833 sharesCommon StockSEC:0001071739-26-000141:0
465 sharesCommon StockSEC:0001071739-26-000142:0
581 sharesCommon StockSEC:0001071739-26-000143:0
61 sharesCommon StockSEC:0001071739-26-000144:0
483 sharesCommon StockSEC:0001071739-26-000129:0
80,000 sharesCommon StockSEC:0001071739-26-000127:0
80,000 shares@ US$64.55280.015% mcap25.6% of flowCommonSEC144:0001959173-26-004540
3,992 shares0Common StockSEC:0001071739-26-000110:0
3,992 shares0Common StockSEC:0001071739-26-000109:0
964 shares@ US$37.260.0001% mcap19.3% of flowCommon StockSEC:0001071739-26-000091:0
1,140 shares0Common StockSEC:0001071739-26-000086:0
1,690 shares0Common StockSEC:0001071739-26-000087:0
943 shares0Common StockSEC:0001071739-26-000088:0
1,179 shares0Common StockSEC:0001071739-26-000089:0
2,918 shares@ US$34.459.9% of flowCommon StockSEC:0001071739-26-000068:0
36,061 shares@ US$34.452.9% of flowCommon StockSEC:0001071739-26-000066:0
25 of 391 declarations
关于 CENTENE CORP
Centene Corp.（股票代码：CNC）是一家在美国纽约证券交易所上市的主要美国管理式医疗保健公司，总部位于密苏里州圣路易斯。该公司成立于 1984 年，当时是密尔沃基的一家名为 Family Hospital Physician Associates (FHPA) 的非营利性医疗补助计划，随后于 1997 年更名为 Centene 并将其公司总部迁至圣路易斯。随着时间的推移，Centene 已从一家地方性安全网保险公司发展成为一个围绕社区运营模式构建的全国性管理式医疗平台。（[centene.com](https://www.centene.com/who-we-are/history.html?utm_source=openai)) Centene 的核心业务围绕三个主要领域展开：医疗补助、医疗保险和健康保险市场。它还报告了一个用于剩余活动的“其他”部门，尽管管理层已表示将更明确地关注其核心平台。该公司称自己是美国最大的医疗补助管理式医疗组织，也是市场领域的长期领导者。其产品组合包括政府资助的健康计划、医疗保险优势计划、医疗保险处方药计划 (PDP) 以及相关的护理管理和健康服务解决方案。（[centene.com](https://www.centene.com/who-we-are/history.html?utm_source=openai)) 从竞争角度来看，Centene 的规模和本地市场方法是其核心差异化因素。该公司业务遍及所有 50 个州，并声称其服务覆盖全国超过 15 分之一的人口。其商业模式受到高度监管且运营复杂，但受益于庞大的会员基础以及在州医疗补助计划和 ACA 市场计划中的多元化布局。然而，最近的披露强调了更具挑战性的运营背景，特别是在医疗补助和市场领域，面临利润压力和持续的投资组合清理。（[centene.com](https://www.centene.com/who-we-are/history.html?utm_source=openai)) 近期发展对投资者而言至关重要。2026 年 2 月 6 日，Centene 公布了 2025 年全年业绩并发布了 2026 年指导，其中包括调整后稀释每股收益指导高于 $3.00，同时强调旨在恢复市场盈利能力和稳定医疗补助轨迹的行动。2025 年 12 月，该公司还签署了一项最终协议，剥离剩余的 Magellan Health 业务，这突显了更广泛的战略简化努力。在 2026 年第一季度更新中，Centene 继续专注于利润改善、成本控制以及其核心业务部门的执行。（[investors.centene.com](https://investors.centene.com/2026-02-06-CENTENE-CORPORATION-REPORTS-2025-RESULTS-AND-ANNOUNCES-2026-GUIDANCE?utm_source=openai)) 对于讲法语的投资者而言，Centene 最好被视为一家管理式医疗和政府项目医疗保健运营商，具有强大的美国规模、防御性的终端市场特征，以及对医疗补助和 ACA 市场中的报销趋势、利用模式和监管变化的显著敏感性。（[centene.com](https://www.centene.com/content/dam/centenedotcom/investor_docs/CNC-2026-Proxy-2025-Annual-Report.pdf?utm_source=openai))
